https://www.selleckchem.com/products/2-d08.html
Our experiments revealed that the carcinogenic effects of in prostate cancer may depend on a new molecular mechanism, which directly alters IDH1 enzyme activity. Our findings indicate that is a novel candidate target for prostate cancer treatment. Our experiments revealed that the carcinogenic effects of IDH1-AS1 in prostate cancer may depend on a new molecular mechanism, which directly alters IDH1 enzyme activity. Our findings indicate that IDH1-AS1 is a novel candidate target for prostate cancer treatment. Pancreatic cancer is a highly
Like
Comment
Share
